Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 7 Affordable and Clean Energy
Fingerprint
- 12 Similar Profiles
Collaborations and top research areas from the last five years
-
Investigating sublethal anthrax infections in African buffalo (Syncerus caffer) of Kruger National Park
Walcheck, B. (PI)
6/1/26 → 8/31/26
Project: Research project
-
BI Veterinary Scholars Program, University of Minnesota Summer 2026
Walcheck, B. (PI)
BOEHRINGER INGELHEIM ANIMAL HEALTH
5/1/26 → 8/31/26
Project: Research project
-
Development of a novel multi-engager antibody complex to augment natural killer cell function and durability in lymphoma
Walcheck, B. (PI), Bachanova, V. (CoI), Felices, M. (CoI) & Rendahl, A. (CoI)
8/15/25 → 8/14/27
Project: Research project
-
NK cells, their receptors, and cancer therapy
Cichocki, F. M. (PI), Felices, M. (PI), Geller, M. A. (PI), Grzywacz, B. J. (PI), Juckett, M. B. (PI), Luo, X. (PI), Miller, J. S. (PI), Rao, J. S. (PI), Walcheck, B. (PI), Weisdorf, D. J. (PI), Bachanova, V. (CoI), Basu, S. (CoI), Brunstein, C. G. (CoI), Davis, Z. B. (CoI), Kennedy, P. (CoI), Le, C. T. (CoI), Starr, T. (CoI), Warlick, E. D. (CoI) & De For, T. E. (Prior Principal Investigator)
4/9/21 → 3/31/27
Project: Research project
-
Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing
Geller, M. A. (PI), Miller, J. S. (PI), Moriarity, B. S. (PI), Walcheck, B. (PI), Rendahl, A. (CoI), Starr, T. (CoI) & Wu, J. (CoI)
4/1/21 → 3/31/27
Project: Research project
-
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity
Dixon, K. J., Hullsiek, R., Wang, S., Friess, R. R., Matson, A. W., Soignier, Y., Lenvik, A. J., Wu, J., Hart, G. T., Felices, M. & Walcheck, B., 2026, In: Frontiers in immunology. 17, 1714022.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Letter to the editor: expanding the discourse on NK cell Fc receptor engineering
Wu, J. & Walcheck, B., 2026, In: Future Virology. 21, 4, p. 251-253 3 p.Research output: Contribution to journal › Letter › peer-review
-
Next-Generation Multi-Engager Complexes Linking Natural Killer Cells to Tumor Cells and Targeting the Proteolytic Checkpoint ADAM17
Dixon, K. & Walcheck, B., Jul 2026, In: Cells. 15, 14, 1269.Research output: Contribution to journal › Review article › peer-review
Open Access -
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity
van Hauten, P. M. M., Hooijmaijers, L., Vidal-Manrique, M., van der Waart, A. B., Hobo, W., Wu, J., Blijlevens, N. M. A., Jansen, J. H., Walcheck, B., Schaap, N. P. M., de Jonge, P. K. J. D. & Dolstra, H., Mar 2024, In: Cytotherapy. 26, 3, p. 252-260 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Matson, A. W., Hullsiek, R., Dixon, K. J., Wang, S., Lindstedt, A. J., Friess, R. R., Phung, S. K., Freedman, T. S., Felices, M., Truckenbrod, E. N., Wu, J., Miller, J. S. & Walcheck, B., Jul 24 2024, In: Journal for ImmunoTherapy of Cancer. 12, 7, e008959.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations